GB201701999D0 - Self-Eliminating linkers - Google Patents
Self-Eliminating linkersInfo
- Publication number
- GB201701999D0 GB201701999D0 GBGB1701999.3A GB201701999A GB201701999D0 GB 201701999 D0 GB201701999 D0 GB 201701999D0 GB 201701999 A GB201701999 A GB 201701999A GB 201701999 D0 GB201701999 D0 GB 201701999D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- self
- linkers
- eliminating
- eliminating linkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1701999.3A GB201701999D0 (en) | 2017-02-07 | 2017-02-07 | Self-Eliminating linkers |
PCT/EP2018/053112 WO2018146166A1 (en) | 2017-02-07 | 2018-02-07 | Heterobifunctional linkers for modifying thiols |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1701999.3A GB201701999D0 (en) | 2017-02-07 | 2017-02-07 | Self-Eliminating linkers |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201701999D0 true GB201701999D0 (en) | 2017-03-22 |
Family
ID=58462299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1701999.3A Ceased GB201701999D0 (en) | 2017-02-07 | 2017-02-07 | Self-Eliminating linkers |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201701999D0 (en) |
WO (1) | WO2018146166A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102267519B1 (en) * | 2020-01-08 | 2021-06-21 | 경희대학교 산학협력단 | Nanoparticles for drug delivery surface-modified with brain tumor cell targeting peptide, preparation method thereof and use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004016801A2 (en) * | 2002-08-16 | 2004-02-26 | Immunogen, Inc. | Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
-
2017
- 2017-02-07 GB GBGB1701999.3A patent/GB201701999D0/en not_active Ceased
-
2018
- 2018-02-07 WO PCT/EP2018/053112 patent/WO2018146166A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2018146166A1 (en) | 2018-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3606954T3 (en) | Anti-LAG3-antistoffer | |
GB201703129D0 (en) | Quibbler | |
DK3734167T3 (en) | Airconditionsystem | |
DK3499914T3 (en) | Høreapparatsystem | |
DK3700925T3 (en) | Hidtil ukendt t-cellereceptor | |
AU201714106S (en) | Mandoline | |
DK3401557T3 (en) | Træskrue | |
IL283682A (en) | Linkers | |
DK3485765T3 (en) | Computerbord | |
DK3630041T3 (en) | Stimulationsapparat | |
DK3718525T3 (en) | Motoriseret asssistancesystem | |
DK3704866T3 (en) | Datatransmissionssystem | |
GB201700825D0 (en) | Poliovaccine | |
GB201701999D0 (en) | Self-Eliminating linkers | |
GB201702641D0 (en) | Easpagnolette | |
GB201820020D0 (en) | Linkers | |
DK3425793T3 (en) | Tagsystem | |
DK3618761T3 (en) | Intrakorporalt perfusionssystem | |
DK3351149T3 (en) | Syltetøjsfontæne | |
GB201718026D0 (en) | Concept nine | |
AU201715236S (en) | Striplight | |
AP00994S1 (en) | Autorickshaw | |
GB201703643D0 (en) | Drydam | |
GB201703535D0 (en) | Signitune | |
GB201703539D0 (en) | Tech-Form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |